Chemical Component Summary

NameTIVOZANIB
Synonyms1-{2-chloro-4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-3-[(3E)-5-methylisoxazol-3(2H)-ylidene]urea
Identifiers(3E)-1-[2-chloranyl-4-(6,7-dimethoxyquinolin-4-yl)oxy-phenyl]-3-(5-methyl-1,2-oxazol-3-ylidene)urea
FormulaC22 H19 Cl N4 O5
Molecular Weight454.86
TypeNON-POLYMER
Isomeric SMILESCC1=C/C(=N\C(=O)Nc2ccc(cc2Cl)Oc3ccnc4c3cc(c(c4)OC)OC)/NO1
InChIInChI=1S/C22H19ClN4O5/c1-12-8-21(27-32-12)26-22(28)25-16-5-4-13(9-15(16)23)31-18-6-7-24-17-11-20(30-3)19(29-2)10-14(17)18/h4-11H,1-3H3,(H2,25,26,27,28)
InChIKeySPMVMDHWKHCIDT-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count51
Chiral Atom Count0
Bond Count54
Aromatic Bond Count17

Drug Info: DrugBank

DrugBank IDDB11800 
NameTivozanib
Groups
  • approved
  • investigational
DescriptionTivozanib has been used in trials studying the treatment and basic science of Solid Tumors, Glioblastoma, Ovarian Cancer, Prostate Cancer, and Stage IV Disease, among others.
Synonyms
  • Tivozanib
  • Tivozanib hydrochloride
Brand NamesFotivda
Categories
  • Antineoplastic Agents
  • Antineoplastic and Immunomodulating Agents
  • Benzene Derivatives
  • Heterocyclic Compounds, Fused-Ring
  • Protein Kinase Inhibitors
ATC-CodeL01XE34
CAS number475108-18-0

Related Resource References

Resource NameReference
PubChem9911830
ChEBICHEBI:91327
ChEMBLCHEMBL1289494
PharosCHEMBL1289494